Guo Li-Min, Lyu Jie-Li, Zhang Lai-Bin
School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China.
Zhongguo Zhong Yao Za Zhi. 2018 Oct;43(20):3989-3999. doi: 10.19540/j.cnki.cjcmm.20180726.013.
Sesquiterpenoid is a kind of compound widely distributed in nature, which has a wide range of biological activities, such as anti-inflammatory, anti-tumor and immunomodulatory activities. This paper would review the anti-inflammatory mechanism of sesquiterpenoid. The mechanism is mainly by inhibiting the activation of nuclear factor (NF-κB), mitogen-activated protein kinase (MAPKs) and signal transducers and activators of transcription (STAT) signaling pathways and down-regulating the inflammatory gene expression including tumor necrosis factor- (TNF-), prostaglandin E₂ (PGE₂), nitric oxide (NO), interleukin-1(IL-1), IL-6, IL-8 and other inflammatory factors. Thereby, the production and release of inflammatory cytokines are reduced to exert anti-inflammatory effect. This review is intended to provide reference for related research.
倍半萜类化合物是一类广泛分布于自然界的化合物,具有广泛的生物活性,如抗炎、抗肿瘤和免疫调节活性。本文将综述倍半萜类化合物的抗炎机制。其机制主要是通过抑制核因子(NF-κB)、丝裂原活化蛋白激酶(MAPKs)和信号转导子及转录激活子(STAT)信号通路的激活,并下调包括肿瘤坏死因子-(TNF-)、前列腺素E₂(PGE₂)、一氧化氮(NO)、白细胞介素-1(IL-1)、IL-6、IL-8等炎性因子在内的炎症基因表达。从而减少炎性细胞因子的产生和释放,发挥抗炎作用。本综述旨在为相关研究提供参考。